2014 APSR Congress
Accepted and Scheduled for Oral Presentation
This page has been reproduced from the website of the
2014 APSR Congress in Bali, Indonesia, 13-16 November 2014
What to do next:
Kindly prepare your presentation in Microsoft Powerpoint format. You will need to submit the files for technical checks. Do not present from your laptop. Kindly ensure you use only Standard Slidesize (4:3). Widescreen will not be displayed. Please ensure all videos, files or images are correctly embedded into the slides (not just linked on computer), so that they will actually display when you are presenting. Following this format guideline would help you enjoy a smoother experience onsite.
What to do onsite:
Please check-in at the registration counter to get your badge first. If you still have not registered, please do so onsite in order to enter the congress. Once done, kindly note that all slides must be submitted:
- 12 Nov 12:00-18:00 Speaker Room (BNDCC Uluwatu 4)
or - 13 Nov 07:00-17:00 Speaker Room (BNDCC Uluwatu 4)
In the case where you are unable to submit your presentation during the above times, please go to the AV desk at your assigned room, at least 1 hour prior to your session. We encourage that you prepare early and submit early by 13 Nov, for smoother outcomes - because, in order to avoid disruptions, priority will be given to the ongoing session first.
What to do during presentation:
10 minutes before your presentation, please move to the Next-Speaker seating section at the front of the hall near the podium. Each author will be allocated strictly 10 minutes ( 5-8 slides ). Time management is essential - try to keep to a 2-minute introduction, 5-minute body content, and 3-minute Q&A. Be considerate of the congress schedule by stayingwithin your allotted time. Thank you and we wish you a fulfilling time at the APSR 2014.
If you have not registered and wish to confirm your withdrawal from the session, please inform us soonest at abstracts@apsr2014.org, with the email subject “Request for Abstract Withdrawal (Assigned #)”.
| Assigned # | Abstract Title | Presenting Author | Oral Presentation Schedule |
|---|---|---|---|
| O-A-001 | Plume temperature and force of fluticasone propionate/formoterol pMDI compared with fluticasone propionate/salmeterol pMDI | JONATHAN MARSHALL | 14 Nov 13:00-14:00 Uluwatu 2 OS 5 Oral Session 5: Asthma Assembly |
| O-A-002 | Therapeutic Effects of Histone Deacetylase Enzyme 6 Inhibitors (HDAC6i) in a Murine Asthma Model | YUAN REN | 14 Nov 13:00-14:00 Uluwatu 2 OS 5 Oral Session 5: Asthma Assembly |
| O-A-003 | Tracheobronchial Wall Vessel Remodeling and Endothelial Cell Activation in a Murine Asthma Model | XINMING SU | 14 Nov 13:00-14:00 Uluwatu 2 OS 5 Oral Session 5: Asthma Assembly |
| O-A-004 | Omalizumab improves quality of life and asthma control in Chinese patients with moderate-to-severe asthma: a randomised phase III study | JING LI | 14 Nov 13:00-14:00 Uluwatu 2 OS 5 Oral Session 5: Asthma Assembly |
| O-A-005 | A novel thromboxane A2 receptor inhibitor, seratrodast shows greater improvement in peak expiratory flow, expectoration score, sputum eosinophil cationic protein and albumin levels as compared to montelukast in a double blind comparative clinical trial. | DR. BHUPESH DEWAN | 14 Nov 13:00-14:00 Uluwatu 2 OS 5 Oral Session 5: Asthma Assembly |
| O-A-006 | Median mass aerodynamic diameter (MMAD) and fine particle fraction (FPF): influence on lung deposition? | JONATHAN MARSHALL | 14 Nov 13:00-14:00 Uluwatu 2 OS 5 Oral Session 5: Asthma Assembly |
| O-A-008 | Asthma severity and phenotypes associated with vocal cord dysfunction | PHILIP BARDIN | 15 Nov 8:00-9:00 Uluwatu 2 OS 12 Oral Session 12: Asthma Assembly |
| O-A-009 | STAT1/STAT6 phosphorylation balancing of CD4+ memory T cells in asthma and COPD | ZHIHONG CHEN | 15 Nov 8:00-9:00 Uluwatu 2 OS 12 Oral Session 12: Asthma Assembly |
| O-A-010 | Add-on effect of Tiotropium bromide to ICS/LABA combination inhaler for peripheral airways among patients with severe uncontrolled asthma | MASAYUKI HOJO | 15 Nov 8:00-9:00 Uluwatu 2 OS 12 Oral Session 12: Asthma Assembly |
| O-A-011 | Identification of Attitudinal Clusters in Patients with Asthma: Analysis from REALISE Asia | SANG HEON CHO | 15 Nov 8:00-9:00 Uluwatu 2 OS 12 Oral Session 12: Asthma Assembly |
| O-A-012 | Early effect of maternal allergic asthma on T-regulatory cells immune response in cord blood of offsprings | JING LIU | 15 Nov 8:00-9:00 Uluwatu 2 OS 12 Oral Session 12: Asthma Assembly |
| O-A-013 | Discrepancy between patient-perception and guideline-defined asthma control in Asia: a survey of over 2400 patients | SANG HEON CHO | 15 Nov 8:00-9:00 Uluwatu 2 OS 12 Oral Session 12: Asthma Assembly |
| O-A-014 | Patterns of hospitalization and healthcare utilization across attitudinal clusters: Analysis from patient survey in Asia | DIAHN-WARNG PERNG | 15 Nov 16:15-17:25 Uluwatu 2 OS 19 Oral Session 19: Asthma Assembly |
| O-A-015 | Increasing Level of Interleukin-10, Interleukin-17 and ACT Scoring in Asthma Bronchial Patient with Vitamin D Deficiency after 2 Months Supplementation of 800 IU Vitamin D | DWI YULIATI | 15 Nov 16:15-17:25 Uluwatu 2 OS 19 Oral Session 19: Asthma Assembly |
| O-A-016 | Patient handling study of fluticasone propionate/formoterol fumarate pressurized metered-dose inhaler | SANJEEVA DISSANAYAKE | 15 Nov 16:15-17:25 Uluwatu 2 OS 19 Oral Session 19: Asthma Assembly |
| O-A-017 | Asthma Self monitoring, Behaviour Modification and Medication Compliance in Comparison to Patients with Hypertension / High Cholesterol and link to Asthma Hospitalisation Profile. | STEBBINGS AMY E L | 15 Nov 16:15-17:25 Uluwatu 2 OS 19 Oral Session 19: Asthma Assembly |
| O-A-018 | Associations of Asthma Control with systemic inflammations | HARUN ISKANDAR | 15 Nov 16:15-17:25 Uluwatu 2 OS 19 Oral Session 19: Asthma Assembly |
| O-A-019 | Long-term Efficacy of Omalizumab in Patients with Severe Asthma | JUNKO SAJI | 15 Nov 16:15-17:25 Uluwatu 2 OS 19 Oral Session 19: Asthma Assembly |
| O-B-001 | Bronchoscopic lipiodol-marking utilizing diagnostic guided-bronchoscopy to facilitate minimal surgery for small pulmonary nodule | MASAFUMI MISAWA | 14 Nov 14:00-15:00 Uluwatu 2 OS 7 Oral Session 7: Bronchoscopy and Interventional Techniques Assembly |
| O-B-002 | Flexible Fibre-optic Bronchoscopy, Obesity and Sleep Disordered Breathing: Patients Characteristics and Complications in 570 Cases | TERENCE S T TING | 15 Nov 8:00-10:00 Uluwatu 1 OS Best Oral Presentation Selection Session |
| O-B-003 | Functional Bronchoscopy in the Management of Airway Stenosis Due to Tracheobronchial Tuberculosis | SEIICHI NOBUYAMA | 14 Nov 14:00-15:00 Uluwatu 2 OS 7 Oral Session 7: Bronchoscopy and Interventional Techniques Assembly |
| O-B-005 | Endobronchial Ultrasound Elastography in the Diagnosis of Mediastinal and Hilar Lymph Nodes | TAKEHIRO IZUMO | 14 Nov 14:00-15:00 Uluwatu 2 OS 7 Oral Session 7: Bronchoscopy and Interventional Techniques Assembly |
| O-B-006 | Talc Poudrage Using Catheter Through Flexi-Rigid Thoracoscope Under Local Anesthesia for Malignant Pleural Effusions | YUKO ISE | 14 Nov 14:00-15:00 Uluwatu 2 OS 7 Oral Session 7: Bronchoscopy and Interventional Techniques Assembly |
| O-C-001 | Activation of lymphocytes induced by RSV persistently infected bronchial epithelial cells | LING QIN | 15 Nov 15:00-16:00 Uluwatu 2 OS 17 Oral Session 17: Cellular and Molecular Biology Assembly |
| O-C-002 | Mesenchymal Stem Cell: Does it Work in an Experimental Model with Acute Respiratory Distress Syndrome? | ERDAL KARAOZ | 15 Nov 15:00-16:00 Uluwatu 2 OS 17 Oral Session 17: Cellular and Molecular Biology Assembly |
| O-C-003 | An in vitro model of sick building syndrome using human bronchial epithelial cells | IKUMI MATSUSHITA | 15 Nov 15:00-16:00 Uluwatu 2 OS 17 Oral Session 17: Cellular and Molecular Biology Assembly |
| O-C-004 | The role of the receptor for advanced glycation end products in LPS-induced lung injury in mice | MEI HE | 15 Nov 15:00-16:00 Uluwatu 2 OS 17 Oral Session 17: Cellular and Molecular Biology Assembly |
| O-C-005 | Role of interferon regulatory factor 1 based on next generation sequencing in mouse model of acute respiratory distress syndrome | Yang Se-Ran | 15 Nov 15:00-16:00 Uluwatu 2 OS 17 Oral Session 17: Cellular and Molecular Biology Assembly |
| O-D-001 | Dynamic change of house dust mites and its components- sIgE&sIgG4 in Specific immunotherapy | Baoqing Sun | 15 Nov 8:00-10:00 Uluwatu 1 OS Best Oral Presentation Selection Session |
| O-D-002 | The dynamic change of inflammatory cytokines treated by specific immunity and the analysis of the dynamic change of house dust mites’ components-IgE&IgG4 | Guangqiao Zeng | 16 Nov 11:00-12:00 Uluwatu 1 OS 28 Oral Session 28: Clinical Allergy Assembly |
| O-D-003 | Tobacco Smoke Exposure Alters Immune Functions Mediated With DNA Damage In Alveolar Macrophage (AM) | MINORU TAKEUCHI | 16 Nov 11:00-12:00 Uluwatu 1 OS 28 Oral Session 28: Clinical Allergy Assembly |
| O-D-004 | FeNO could be an effective predictor for eosinophilic inflammation in young adult patients with allergic rhinitis | BAOJUAN LIU | 16 Nov 11:00-12:00 Uluwatu 1 OS 28 Oral Session 28: Clinical Allergy Assembly |
| O-D-005 | Induced Pluripotent Stem Cells Reduces Neutrophils Chemotaxis via Activating GRK2 in Endotoxin-induced Acute Lung Injury | VINCENT YI-FONG SU | 16 Nov 11:00-12:00 Uluwatu 1 OS 28 Oral Session 28: Clinical Allergy Assembly |
| O-D-006 | Effects of familial inheritance on regulation of Th1/Th2 cytokine expression | JIAYING LUO | 16 Nov 11:00-12:00 Uluwatu 1 OS 28 Oral Session 28: Clinical Allergy Assembly |
| O-E-001 | Factors associated with radiologic progression of non-cystic fibrosis bronchiectasis during long term follow up | JAE HO LEE | 14 Nov 16:15-17:25 Uluwatu 2 OS 10 Oral Session 10: Clinical Respiratory Medicine Assembly |
| O-E-002 | Thromboembolic events in malignant pleural mesothelioma | DENIZ KOKSAL | 14 Nov 16:15-17:25 Uluwatu 2 OS 10 Oral Session 10: Clinical Respiratory Medicine Assembly |
| O-E-003 | Impact of ancilliary findings in patients with suspected pulmonary embolism. | MARIKA BAJC | 14 Nov 16:15-17:25 Uluwatu 2 OS 10 Oral Session 10: Clinical Respiratory Medicine Assembly |
| O-E-004 | Preparation and Characterization of Controlled Release Microspheres for Management of Pulmonary Hypertension |
APARNA SAIGAL | 14 Nov 16:15-17:25 Uluwatu 2 OS 10 Oral Session 10: Clinical Respiratory Medicine Assembly |
| O-E-005 | Pregnancy doesn’t always cause deterioration of lymphangioleiomyomatosis | KATSUTOSHI ANDO | 14 Nov 16:15-17:25 Uluwatu 2 OS 10 Oral Session 10: Clinical Respiratory Medicine Assembly |
| O-E-007 | A Multi-Disciplinary Survey on Attitudes and Perceptions on Adult Outpatient Tracheostomy Care in the Philippine General Hospital | JOHANN PAOLO AUGUSTO D. ALMAZAR | 14 Nov 16:15-17:25 Uluwatu 2 OS 10 Oral Session 10: Clinical Respiratory Medicine Assembly |
| O-F-001 | Long acting beta 2 agonist inhibits cigarette smoke-induced airway inflammation and remodeling through cAMP pathway | YI-HAN HSIAO | 14 Nov 13:00-14:00 Uluwatu 3 OS 6 Oral Session 6: COPD Assembly |
| O-F-002 | Methylation status of perforin gene promoter in CD4+T lymphocytes of patients with chronic obstructive pulmonary disease | LIN LIU | 14 Nov 13:00-14:00 Uluwatu 3 OS 6 Oral Session 6: COPD Assembly |
| O-F-004 | Vitamin D Inhibits Expression and Activity of matrix metalloproteinase (MMP) in Human Lung Fibroblasts (HFL-1) Cells. |
HUI JUNG KIM | 14 Nov 13:00-14:00 Uluwatu 3 OS 6 Oral Session 6: COPD Assembly |
| O-F-006 | Mild to Moderate Airflow Obstruction is not Directly Associated with Coronary Arteriosclerosis but is Associated with the Elevation of Serum Creatinine Levels | TAKEHIKO KOBAYASHI | 15 Nov 8:00-10:00 Uluwatu 1 OS Best Oral Presentation Selection Session |
| O-F-007 | miR-146a Plays Pathogenic Role in Abnormal Inflammatory Response of a Murine COPD Model | HARIO BASKORO | 14 Nov 13:00-14:00 Uluwatu 3 OS 6 Oral Session 6: COPD Assembly |
| O-F-008 | EVALUATING DRUG UTILISATION PATTERN AND DIRECT COST OF CRITICAL CARE MANAGEMENT IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE IN MANGALORE, INDIA. | AISWARYA ARAVIND | 14 Nov 13:00-14:00 Uluwatu 3 OS 6 Oral Session 6: COPD Assembly |
| O-F-009 | Eosinopenia as a Marker of Outcome in Acute Exacerbations of Chronic Obstructive Pulmonary Disease | SHAGAYEGH RAHIMIRAD | 14 Nov 14:00-15:00 Uluwatu 3 OS 8 Oral session 8: COPD Assembly |
| O-F-010 | Decrease Of Interleukin 6 Serum Level, Improvement Of SGRQ And Depresion Comorbid In COPD Patient Population With Which Are Treated With Medical Rehabilitation | UNGKY AGUS SETYAWAN | 14 Nov 14:00-15:00 Uluwatu 3 OS 8 Oral session 8: COPD Assembly |
| O-F-011 | MEF50/MEF25 and RV/TLC% correlate with HRCT phenotypes of COPD | XIAN WEN SUN | 15 Nov 8:00-10:00 Uluwatu 1 OS Best Oral Presentation Selection Session |
| O-F-012 | A summary of the difficulties in diagnosis and treatment of elderly patients with chronic obstructive pulmonary disease | QIAO YU | 14 Nov 14:00-15:00 Uluwatu 3 OS 8 Oral session 8: COPD Assembly |
| O-F-013 | Clinical Impact of Combined Viral and Bacterial Infection in COPD Patients with Community-Onset Pneumonia | KEI NAKASHIMA | 14 Nov 14:00-15:00 Uluwatu 3 OS 8 Oral session 8: COPD Assembly |
| O-F-014 | Higher circulating IL-13 in biomass-related COPD compared to smokers with or without COPD | SUMEET NAWANI | 14 Nov 14:00-15:00 Uluwatu 3 OS 8 Oral session 8: COPD Assembly |
| O-F-016 | TNF-α RELATIONSHIP ON AIR FLOW RESISTANCE MECHANISM OF COPD | NIA MARNA PREMESTI | 14 Nov 14:00-15:00 Uluwatu 3 OS 8 Oral session 8: COPD Assembly |
| O-F-017 | The efficacy and safety of inhaled umeclidinium bromide/vilanterol in Asian patients with chronic obstructive pulmonary disease | JINPING ZHENG | 15 Nov 14:00-15:10 Uluwatu 3 OS 16 Oral Session 16: COPD Assembly |
| O-F-018 | Clinical Significance of Interleukin (IL)-33 in Chronic Obstructive Pulmonary Disease | CHIN KOOK RHEE | 15 Nov 14:00-15:10 Uluwatu 3 OS 16 Oral Session 16: COPD Assembly |
| O-F-019 | Number of pack year smoked decreases the distance travelled in 6MWT | MOHIT BHATIA | 15 Nov 14:00-15:10 Uluwatu 3 OS 16 Oral Session 16: COPD Assembly |
| O-F-020 | The diagnostic value of Macao predictive values in chronic obstructive lung disease of advanced age by impulse oscillometry | ZHANG XIAO ZHAN | 15 Nov 14:00-15:10 Uluwatu 3 OS 16 Oral Session 16: COPD Assembly |
| O-F-021 | Hydrogen sulfide attenuates airway inflammation in rats with chronic obstructive pulmonary disease | BAI-MEI HE | 15 Nov 14:00-15:10 Uluwatu 3 OS 16 Oral Session 16: COPD Assembly |
| O-F-022 | Differences between CAT and mMRC in Korean COPD patients. | CHIN KOOK RHEE | 15 Nov 14:00-15:10 Uluwatu 3 OS 16 Oral Session 16: COPD Assembly |
| O-F-023 | Risk factors for discontinuation of roflumilast in COPD patients. | CHIN KOOK RHEE | 15 Nov 14:00-15:10 Uluwatu 3 OS 16 Oral Session 16: COPD Assembly |
| O-G-001 | Difference in outcomes between senior physician and medicine resident led code blues | REBECCA E. SELL | 15 Nov 14:00-16:00 Uluwatu 7 YI 1 Young Investigator Awards Session |
| O-G-002 | Evaluation of Impact of Protective Over-shoes on Floor Contamination of ICUs. Is the Practice a Paradigm? | MOHAMMAD HOSEEIN RAHIMIRAD | 15 Nov 15:20-16:00 Uluwatu 3 OS 18 Oral Session 18: Critical Care Assembly |
| O-G-003 | Evaluation of thrombocytopenia and its trend as a marker of mortality in medical Intensive Care Unit patients | MOHAMMADHOSSEIN RAHIMIRAD | 15 Nov 15:20-16:00 Uluwatu 3 OS 18 Oral Session 18: Critical Care Assembly |
| O-G-005 | Initial end-tidal carbon dioxide as a prognostic indicator for inpatient PEA arrest | REBECCA E SELL | 16 Nov 10:00-11:00 Uluwatu 7 OS 27 Oral Session 27: Critical Care Assembly |
| O-G-006 | Outcomes of Early Sedation versus No Sedation among Mechanically Ventilated Critically Ill Patients: A Prospective Comparative Study | YOSHIKO IKEDA-MAQUILING | 16 Nov 10:00-11:00 Uluwatu 7 OS 27 Oral Session 27: Critical Care Assembly |
| O-G-007 | Accuracy of capillary versus venous blood glucose estimation in critically ill adult patients: an observational study | RAHUL KUMAR SHARMA | 16 Nov 10:00-11:00 Uluwatu 7 OS 27 Oral Session 27: Critical Care Assembly |
| O-G-009 | Efficacy of Bi-level Positive Pressure Ventilation (BiPAP) over invasive ventilation in Acute Exacerbation of COPD with Type 2 Respiratory Failure patients in a critical care setting | MD. MAMUNUR RASHID | 16 Nov 10:00-11:00 Uluwatu 7 OS 27 Oral Session 27: Critical Care Assembly |
| O-H-001 | Adverse Respiratory Health Effects of Tear Gas | Benjamas Chuaychoo | 15 Nov 16:15-17:15 Uluwatu 3 OS 20 Oral Session 20: Environmental & Occupational Health and Epidemiology Assembly |
| O-H-002 | Effect of Incomplete Smoking Cessation with Varenicline or Nicotine Patch on Vascular Endothelial Function as Assessed by Flow-Mediated Vasodilation |
AKIRA UMEDA | 15 Nov 16:15-17:15 Uluwatu 3 OS 20 Oral Session 20: Environmental & Occupational Health and Epidemiology Assembly |
| O-H-003 | Newly established ELISA for N-ERC/mesothelin improves diagnostic accuracy in patients with suspected pleural mesothelioma | TADASHI SATO | 15 Nov 16:15-17:15 Uluwatu 3 OS 20 Oral Session 20: Environmental & Occupational Health and Epidemiology Assembly |
| O-H-004 | Welders’ Siderosis: a Retrospective Cohort Study on Welder’s Pneumoconiosis Patients with Small Round Opacities on Chest Radiograph | LING MAO | 15 Nov 16:15-17:15 Uluwatu 3 OS 20 Oral Session 20: Environmental & Occupational Health and Epidemiology Assembly |
| O-H-005 | Indoor PM2.5 and CO levels while burning mosquito coils and its associated respiratory morbidity. | Rahul Kodgule | 15 Nov 16:15-17:15 Uluwatu 3 OS 20 Oral Session 20: Environmental & Occupational Health and Epidemiology Assembly |
| O-I-001 | Efficacy and safety of nintedanib in patients with idiopathic pulmonary fibrosis: Results of two 52-week, Phase III, randomized, placebo-controlled trials (INPULSIS™) | DONG SOON KIM | 14 Nov 8:00-9:30 Uluwatu 7 OS 1 Oral Session 1: Interstitial Lung Disease Assembly |
| O-I-002 | Clinical characteristics of secondary pulmonary alveolar proteinosis (sPAP): the reason for the difficulty of diagnosis as sPAP. (JSPS KAKENHI Grant Number 26305028) | HARUYUKI ISHII | 14 Nov 8:00-9:30 Uluwatu 7 OS 1 Oral Session 1: Interstitial Lung Disease Assembly |
| O-I-003 | Long term follow-up of serum autoantibody against GM-CSF levels in patients with autoimmune pulmonary alveolar proteinosis | AKIKO MATSUMURO | 14 Nov 8:00-9:30 Uluwatu 7 OS 1 Oral Session 1: Interstitial Lung Disease Assembly |
| O-I-005 | A pre-clinical study for development of a new GM-CSF inhalation drug as a treatment of pulmonary alveolar proteinosis | RYUSHI TAZAWA | 14 Nov 8:00-9:30 Uluwatu 7 OS 1 Oral Session 1: Interstitial Lung Disease Assembly |
| O-I-006 | Transbronchial lung biopsy for the diagnosis of lymphangioleiomyomatosis | TARO KOBA | 14 Nov 8:00-9:30 Uluwatu 7 OS 1 Oral Session 1: Interstitial Lung Disease Assembly |
| O-I-007 | Subgroup analysis of Asian patients in the INPULSIS™ trials of nintedanib in idiopathic pulmonary fibrosis | HIROYUKI TANIGUCHI | 14 Nov 8:00-9:30 Uluwatu 7 OS 1 Oral Session 1: Interstitial Lung Disease Assembly |
| O-I-008 | Cytokine profile of lung tissues and serum in patients with interstitial lung diseases | XIAOHONG CHEN | 14 Nov 8:00-9:30 Uluwatu 7 OS 1 Oral Session 1: Interstitial Lung Disease Assembly |
| O-I-009 | Predictive factors for the effect of pirfenidone in idiopathic pulmonary fibrosis | YASUNORI ICHIMURA | 14 Nov 8:00-9:30 Uluwatu 7 OS 1 Oral Session 1: Interstitial Lung Disease Assembly |
| O-I-010 | Experimental study of hypersensitivity pneumonitis in guinea pig induced by inhalation of hair dye ingredients | YUAN REN | 14 Nov 8:00-9:30 Uluwatu 7 OS 1 Oral Session 1: Interstitial Lung Disease Assembly |
| O-I-011 | Case Analysis of Interstitial Lung Diseases Induced By Breast Cancer Chemotherapy | HIROSHI NAKAOKA | 16 Nov 10:00-11:00 Uluwatu 5 OS 26 Oral Session 26: Interstitial Lung Disease Assembly |
| O-I-012 | FLUOROFENIDONE ATTENUATES BLM-INDUCED PULMONARY INFLAMMATION AND FIBROSIS IN MICE VIA INHIBITING THE ACITIVATION OF NALP3 INFLAMMASOME AND IL-1β/IL-1R1/MyD88 SIGNALING PATHWAY | MENG JIE | 16 Nov 10:00-11:00 Uluwatu 5 OS 26 Oral Session 26: Interstitial Lung Disease Assembly |
| O-I-013 | Preparation of Lung-Targeting, Emodin-Loaded PLGA Microspheres and Their Properties | XIAOHONG CHEN | 16 Nov 10:00-11:00 Uluwatu 5 OS 26 Oral Session 26: Interstitial Lung Disease Assembly |
| O-I-014 | Improvement of autoimmune pulmonary alveolar proteinosis after infectious episodes |
TAKEHIKO KOBAYASHI | 16 Nov 10:00-11:00 Uluwatu 5 OS 26 Oral Session 26: Interstitial Lung Disease Assembly |
| O-I-015 | Sarcoidosis- Indian Perspective | MAHAVIR MODI | 16 Nov 10:00-11:00 Uluwatu 5 OS 26 Oral Session 26: Interstitial Lung Disease Assembly |
| O-J-002 | miR-15a Induces Cell Apoptosis and Inhibits Metastasis by Targeting BCL2L2 in Non Small Cell Lung Cancer | YANG TIAN | 15 Nov 16:15- 17:45 Uluwatu 7 YI 2 Young Investigator Awards Session |
| O-J-003 | Simple shipping procedure using filter paper for detection of EGFR and KRAS mutation in malignant pleural fluid from remote area in Indonesia: preliminary study | ASEP RIDWANULLOH | 15 Nov 8:00-10:00 Uluwatu 1 OS Best Oral Presentation Selection Session |
| O-J-004 | Simple latex baloon reservoir system for exhaled breath condensate as noninvasive molecular diagnostic methods in lung cancer: preliminary study | ACHMAD HUDOYO | 14 Nov 15:15-16:15 Uluwatu 2 OS 9 Oral Session 9: Lung Cancer Assembly |
| O-J-005 | Epigenetic alterations of IGF1 regulate TAZ expression in lung cancer | MIAN XIE | 14 Nov 15:15-16:15 Uluwatu 2 OS 9 Oral Session 9: Lung Cancer Assembly |
| O-J-006 | Translational Evidence of Zinc-finger E-box binding homeobox 1 Involvement in Acquired Resistance to Gefitinib in Non-small Cell Lung Cancer | FARIZ NURWIDYA | 15 Nov 8:00-10:00 Uluwatu 1 OS Best Oral Presentation Selection Session |
| O-J-007 | CONSTRUCTION OF EXPRESSION VECTOR, ESTABLISHMENT OF STABLY TRANSFECTED A549 CELL LINE AND PRELIMINARY RESEARCH ON THE FUNCTION OF RBM5 GENE | BIXIU HE | 14 Nov 15:15-16:15 Uluwatu 2 OS 9 Oral Session 9: Lung Cancer Assembly |
| O-J-008 | Cisplatin-induced downregulation of RBM5 increases drug resistance by activating autophagy in non-small cell lung cancer cells | WANG KE | 14 Nov 15:15-16:15 Uluwatu 2 OS 9 Oral Session 9: Lung Cancer Assembly |
| O-J-009 | A specific serum chemokine network correlates with tumorigenesis in and prognosis of patients with non-small cell lung cancer | DAWEI YANG | 15 Nov 14:00-15:00 Uluwatu 2 OS 15 Oral Session 15: Lung Cancer Assembly |
| O-J-010 | Kruppel-Like Factor 2 improves postoperative prognosis of lung adenocarcinoma patients | MEIJI ITAKURA | 15 Nov 14:00-15:00 Uluwatu 2 OS 15 Oral Session 15: Lung Cancer Assembly |
| O-J-011 | Improving the quality of life for ambulatory patients with advance lung cancer through Phone Triaging | ALJOHANI, ABDULAZIZ | 15 Nov 14:00-15:00 Uluwatu 2 OS 15 Oral Session 15: Lung Cancer Assembly |
| O-J-012 | Differentially Expressed Glycosylated Patterns of Alpha-1-Antitrypsin as Serum Biomarkers for the Diagnosis of Lung Cancer | YIQIAN LIANG | 15 Nov 14:00-15:00 Uluwatu 2 OS 15 Oral Session 15: Lung Cancer Assembly |
| O-J-013 | EPIDERMAL GROWH FACTOR RECEPTOR MUTATIONS IN LUNG SQUAMOUS CELL CARCINOMA IN SMOKERS AND NEVER SMOKERS |
TAN JIUNN LIANG | 15 Nov 14:00-15:00 Uluwatu 2 OS 15 Oral Session 15: Lung Cancer Assembly |
| O-J-014 | Study of mechanism of reverse of COX-2 inhibitor celecoxib on acquired resistance to gefitinib in non-small cell lung cancer | QIN-FANG DENG | 15 Nov 14:00-15:00 Uluwatu 2 OS 15 Oral Session 15: Lung Cancer Assembly |
| O-J-015 | Diagnostic Time for Lung Cancer Patients and The Role of A Serum Based Biomarker Panel in The Early Diagnosis for A Cohort of High-risk Patients | DAWEI YANG | 16 Nov 8:00-9:30 Uluwatu 1 OS 21 Oral Session 21: Lung Cancer Assembly |
| O-J-016 | Palladium (II)-saccharinate complex of terpyridine seems to be a promising novel compound for the treatment of lung cancer in vitro | ENGIN ULUKAYA | 16 Nov 8:00-9:30 Uluwatu 1 OS 21 Oral Session 21: Lung Cancer Assembly |
| O-J-018 | High-dose cisplatin exposure increased autophagy and caused cisplatin resistance in human lung cancer A549 cells | KE WANG | 16 Nov 8:00-9:30 Uluwatu 1 OS 21 Oral Session 21: Lung Cancer Assembly |
| O-J-019 | Genetic analysis of hypoxia inducible factor-2 alpha in lung cancer | ANDIKA CHANDRA PUTRA | 16 Nov 8:00-9:30 Uluwatu 1 OS 21 Oral Session 21: Lung Cancer Assembly |
| O-J-020 | Oncological emergencies arising at diagnosis of lung cancer in our hospital | MASAOMI MARUKAWA | 16 Nov 8:00-9:30 Uluwatu 1 OS 21 Oral Session 21: Lung Cancer Assembly |
| O-J-021 | Afatinib in management of non-small cell lung cancer (NSCLC): What is evidence so far? | LUKE LIN | 16 Nov 8:00-9:30 Uluwatu 1 OS 21 Oral Session 21: Lung Cancer Assembly |
| O-J-022 | FREQUENCY OF EPIDERMAL GROWH FACTOR RECEPTOR MUTATIONS IN SQUAMOUS CELL CARCINOMA OF THE LUNG IN SMOKERS AND NEVER SMOKERS | CHONG-KIN LIAM | 16 Nov 8:00-9:30 Uluwatu 1 OS 21 Oral Session 21: Lung Cancer Assembly |
| O-K-001 | Associations of sRAGE and S100A12 on postoperative respiratory complications according to different two ventilation modes after laparoscopic-assisted colorectal surgery | SO YOUNG YANG | 15 Nov 14:00-16:00 Uluwatu 7 YI 1 Young Investigator Awards Session |
| O-K-002 | THE ASSOCIATION OF OXYGEN DESATURATION INDEX AND LIPOPROTEIN PHOSPHOLIPASE A2 TOWARDS CORONARY ARTERY DISEASE IN OBSTRUCTIVE SLEEP APNEA MALE SUBJECTS | ALLEN WIDYSANTO | 16 Nov 8:00-9:00 Uluwatu 5 OS 22 Oral Session 22: Others |
| O-K-003 | The correlation analysis between smoking and the distal lower limb arterial abnormality as detected by IRTI and CPUS in a double blind controlled clinical study | FANGGE DENG | 16 Nov 8:00-9:00 Uluwatu 5 OS 22 Oral Session 22: Others |
| O-K-004 | Long-term Results of Smoking Cessation and Factors Influencing the Success of Smoking Cessation |
NURGÜL BOZKURT | 16 Nov 8:00-9:00 Uluwatu 5 OS 22 Oral Session 22: Others |
| O-K-005 | Syringo-Pleural Shunt after fifteen years- A rare cause of Recurrent Pleural Effusion. | PRAKASH K ASHISH | 16 Nov 8:00-9:00 Uluwatu 5 OS 22 Oral Session 22: Others |
| O-K-007 | ASSESSMENT OF KNOWLEDGE, ACCESSIBILITY AND UTILIZATION OF PALLIATIVE CARE SERVICES AMONG ADULT CANCER PATIENTS AT TIKUR ANBESA SPECIALIZED HOSPITAL, ADDIS ABABA, ETHIOPIA, 2014. | SERAWIT LAKEW CHILLO | 16 Nov 8:00-9:00 Uluwatu 5 OS 22 Oral Session 22: Others |
| O-L-001 | Lung Function Among Early Adolescents Delivered Term with Low Birth Weight | JOJE B. UNDAR | 16 Nov 9:00-10:00 Uluwatu 5 OS 24 Oral Session 24: Respiratory Structure and Function Assembly |
| O-L-002 | IDENTIFICATION OF MMP DYSREGULATION IN EARLY CF - EVIDENCE BASED RATIONALE FOR ANTI-PROTEASE THERAPY | LUKE WISELY GARRATT | 15 Nov 16:15- 17:45 Uluwatu 7 YI 2 Young Investigator Awards Session |
| O-L-003 | Determinants of annual change in peak expiratory flow rate (PEFR) and peak inspiratory flow rate (PIFR) values in a cohort of Indian children aged 4-10 yrs. | Rahul Kodgule | 15 Nov 8:00-10:00 Uluwatu 1 OS Best Oral Presentation Selection Session |
| O-L-004 | Identifying early signs and symptoms of impending asthma exacerbations in children | Katherine Rivera-Spoljaric | 15 Nov 14:00-16:00 Uluwatu 7 YI 1 Young Investigator Awards Session |
| O-M-001 | Reference values for normal pulmonary artery diameter, ratio of pulmonary artery to aorta by CT scan in Korean population | SANG HOON LEE | 14 Nov 8:00-9:30 Uluwatu 2 OS 2 Oral Session 2: Pulmonary Circulation Assembly |
| O-M-002 | Comparison serum CA-125 Level in patients with chronic obstructive pulmonary disease with and without pulmonary hypertension | MOHMMADHOSSEIN RAHIMIRAD | 14 Nov 8:00-9:30 Uluwatu 2 OS 2 Oral Session 2: Pulmonary Circulation Assembly |
| O-M-003 | Effect of thrombomodulin alpha for disseminated intravascular coagulation treatment in patients with lung cancer. | KENTARO NAKANO | 14 Nov 8:00-9:30 Uluwatu 2 OS 2 Oral Session 2: Pulmonary Circulation Assembly |
| O-M-004 | Clinical Conundrum in Pulmonary Embolism Diagnosis: Management of Imaging Discordance (Negative CT Pulmonary Angiography and High probability Ventilation-Perfusion Scan); a case series. | VICKY CHANG | 14 Nov 8:00-9:30 Uluwatu 2 OS 2 Oral Session 2: Pulmonary Circulation Assembly |
| O-M-005 | The Correlation Between CD4 Level and Left Ventricular Systolic Function in HIV/AIDS Patients |
Amir MUZAKKIR | 14 Nov 8:00-9:30 Uluwatu 2 OS 2 Oral Session 2: Pulmonary Circulation Assembly |
| O-N-001 | Correlation Between Endotracheal Aspirate Gram Stain and Results of Bacterial Culture among ICU Patients Admitted in a Tertiary Hospital in Cebu from September 2009 to August 2010: A Retrospective Study. | BEATRIZ C. TAN | 15 Nov 8:00-10:00 Uluwatu 1 OS Best Oral Presentation Selection Session |
| O-N-002 | The Pathophysiological Comparison of Secondary Pneumococcal Pneumonia After H1N1 Pandemic 2009 or H1N1 New Caledonia Influenza |
Masafumi Seki | 14 Nov 8:00-9:30 Uluwatu 3 OS 3 Oral Session 3: Respiratory Infections (Non-tuberculosis) Assembly |
| O-N-003 | Investigation of the antibacterial mechanism of eugenol and cinnamaldehyde on Legionella pneumophila. | JIANGWEI MA | 14 Nov 8:00-9:30 Uluwatu 3 OS 3 Oral Session 3: Respiratory Infections (Non-tuberculosis) Assembly |
| O-N-004 | Long-term macrolide antibiotic therapy may prevent the development of pneumonia in the elderly | HIROKI YOSHIKAWA | 14 Nov 8:00-9:30 Uluwatu 3 OS 3 Oral Session 3: Respiratory Infections (Non-tuberculosis) Assembly |
| O-N-007 | Are there any differences on clinical menifestations of community acquired pneumonia according to presence of non-tuberculous mycobacterium? | BYOUNG-HOON LEE | 14 Nov 8:00-9:30 Uluwatu 3 OS 3 Oral Session 3: Respiratory Infections (Non-tuberculosis) Assembly |
| O-N-008 | Dynamic Chest Imaging Evaluation in Severe Avian Influenza H7N9 Virus Infected Patients: A Retrospective Small-scale Study | CHENG CHEN | 15 Nov 8:00-10:00 Uluwatu 1 OS Best Oral Presentation Selection Session |
| O-N-009 | Incremental Prognostic Predict Ability of Chest Computed Tomography in Patients with Community Onset Pneumonia | NEMOTO MASAHIRO | 14 Nov 8:00-9:30 Uluwatu 3 OS 3 Oral Session 3: Respiratory Infections (Non-tuberculosis) Assembly |
| O-N-010 | Common presentation of uncommon infection : A case of Pulmonary Actinomycosis | DUSHANTHA MADEGEDARA | 14 Nov 8:00-9:30 Uluwatu 3 OS 3 Oral Session 3: Respiratory Infections (Non-tuberculosis) Assembly |
| O-N-011 | Prognostic Factors of Mortality in Patients with Drug-resistant Acinetobacter baumannii Ventilator- associated Pneumonia | Juthamas Inchai | 14 Nov 8:00-9:30 Uluwatu 3 OS 3 Oral Session 3: Respiratory Infections (Non-tuberculosis) Assembly |
| O-N-012 | Antibiotic use for respiratory tract infections in children | PRAMIL TIWARI | 16 Nov 8:00-9:00 Uluwatu 7 OS 23 Oral Session 23: Respiratory Infections (Non-tuberculosis) Assembly |
| O-N-013 | Heart rate variability as a tool to assess the severity of community-acquired pneumonia in hospitalized patients: Preliminary results |
HEAN OOI | 16 Nov 8:00-9:00 Uluwatu 7 OS 23 Oral Session 23: Respiratory Infections (Non-tuberculosis) Assembly |
| O-N-015 | Nontuberculous Mycobacteria Lung Infection In Bronchiectasis In China: Prevalence And Clinical Characteristics | XU JIN-FU | 16 Nov 8:00-9:00 Uluwatu 7 OS 23 Oral Session 23: Respiratory Infections (Non-tuberculosis) Assembly |
| O-N-016 | Association Between Interleukin-6 Serum Level with Treatment Failure of Community Acquired Pneumonia Patients with Comorbids COPD and Heart Failure | CATUR ELVI PURNAMAWATI | 16 Nov 9:00-10:00 Uluwatu 7 OS 25 Oral Session 25: Respiratory Infections (Non-tuberculosis) Assembly |
| O-N-017 | Investigation of the molecular regulating effect of promoter-associated spacer sequences on CTX-M expression | LIN LIU | 16 Nov 9:00-10:00 Uluwatu 7 OS 25 Oral Session 25: Respiratory Infections (Non-tuberculosis) Assembly |
| O-N-018 | COMMUNITY-ACQUIRED PNEUMONIAS IN DIFFERENT AGE GROUPS ON DATA OF THE FAR EAST OF RUSSIA | MARTYNOVA ALINA V | 16 Nov 9:00-10:00 Uluwatu 7 OS 25 Oral Session 25: Respiratory Infections (Non-tuberculosis) Assembly |
| O-N-019 | Characterisation of human metapneumovirus infection of primary human airway cells | PHILIP BARDIN | 16 Nov 9:00-10:00 Uluwatu 7 OS 25 Oral Session 25: Respiratory Infections (Non-tuberculosis) Assembly |
| O-O-001 | Familial aggregation of obstructive sleep apnoea using children probands – obesity makes the difference | ALBERT MARTIN LI | 14 Nov 13:00 14:00 Uluwatu 6 OS 4 Oral Session 4: Respiratory Neurobiology and Sleep Assembly |
| O-O-002 | Familial aggregation of obstructive sleep apnoea in children without tonsillar hypertrophy | ALBERT MARTIN LI | 14 Nov 13:00 14:00 Uluwatu 6 OS 4 Oral Session 4: Respiratory Neurobiology and Sleep Assembly |
| O-O-003 | Evaluation of brainstem auditory evoked potentials in male patients with moderate and severe obstructive sleep apnea syndrome | JIAO SU | 15 Nov 8:00-10:00 Uluwatu 1 OS Best Oral Presentation Selection Session |
| O-O-004 | 5-HT1A receptor in raphe magnus nucleus modulates ventilatory long-term facilitation induced by chronic intermittent hypoxia | JIAO SU | 14 Nov 13:00 14:00 Uluwatu 6 OS 4 Oral Session 4: Respiratory Neurobiology and Sleep Assembly |
| O-O-006 | 5-HT1A receptor in raphe dorsal nucleus modulates genioglossus corticomotor activity during acute intermittent hypoxia | WEI WANG | 14 Nov 13:00 14:00 Uluwatu 6 OS 4 Oral Session 4: Respiratory Neurobiology and Sleep Assembly |
| O-O-007 | The Obstructive Sleep Apnea and Ischemic Heart Disease Study | D J CHRISTOPHER | 14 Nov 13:00 14:00 Uluwatu 6 OS 4 Oral Session 4: Respiratory Neurobiology and Sleep Assembly |
| O-P-001 | The Role of Nitric Oxide in Tracheobronchial Ciliary Motility. | TAKASHI KIDO | 16 Nov 9:00-10:00 Uluwatu 5 OS 24 Oral Session 24: Respiratory Structure and Function Assembly |
| O-P-002 | Age As The Main Predictor In Correlating Blood Pressure And Lung Function In Malaysian Population | NURUL YAQEEN MOHD ESA | 16 Nov 9:00-10:00 Uluwatu 5 OS 24 Oral Session 24: Respiratory Structure and Function Assembly |
| O-P-004 | The relationship between collagen fiber orientation and anisotropy in mechanical property on the human lung | KOICHI TOMODA | 16 Nov 9:00-10:00 Uluwatu 5 OS 24 Oral Session 24: Respiratory Structure and Function Assembly |
| O-Q-001 | Clinical Benefit of Delamanid (OPC-67683) in the Treatment of Multidrug-Resistant Tuberculosis Patients in China | QING ZHANG | 14 Nov 16:15-17:45 Uluwatu 3 OS 11 Oral Session 11: Tuberculosis Assembly |
| O-Q-003 | Xpert MTB/RIF testing of Pooled Induced Sputum | T.K. LIM | 14 Nov 16:15-17:45 Uluwatu 3 OS 11 Oral Session 11: Tuberculosis Assembly |
| O-Q-004 | A case-control comparison of the Mantoux test and a commercial interferon gamma release assay (IGRA) in adults: First report in a Sri Lankan setting. | CHAMPA NEELAKANTHI RATNATUNGA | 15 Nov 8:00-10:00 Uluwatu 1 OS Best Oral Presentation Selection Session |
| O-Q-006 | Analysis of Medical Burden of TB Patients in DOTs of Taiwan health insurance | TSUNG HSIEN YANG | 14 Nov 16:15-17:45 Uluwatu 3 OS 11 Oral Session 11: Tuberculosis Assembly |
| O-Q-007 | Comparison of characteristics of patients with tuberculosis diagnosed and not diagnosed by fiberoptic bronchoscopy | TSUGITOSHI ONUKI | 14 Nov 16:15-17:45 Uluwatu 3 OS 11 Oral Session 11: Tuberculosis Assembly |
| O-Q-008 | Clinical and bronchoscopic characteristics of patients diagnosed with endobronchial tuberculosis (EBTB) at Selayang Hospital, Selangor Malaysia | SITI KAMARIAH OTHMAN | 14 Nov 16:15-17:45 Uluwatu 3 OS 11 Oral Session 11: Tuberculosis Assembly |
| O-Q-009 | Audit of Tuberculosis Treatment Interrupters in Kandy District, Sri Lanka | DHAMITH NANDADEVA | 14 Nov 16:15-17:45 Uluwatu 3 OS 11 Oral Session 11: Tuberculosis Assembly |
| O-Q-010 | Prospective Study: IL-10 And IL-17 Plasma Levels During Oral Antituberculosis Treatment With Sputum Conversion And Successful Treatment in Active Lung Tuberculosis patient. | FITRI EMIZOLA | 14 Nov 16:15-17:45 Uluwatu 3 OS 11 Oral Session 11: Tuberculosis Assembly |
| O-Q-011 | The Profile of Matrix Metalloproteinase-9 (MMP-9) Serum Levels and its Correlation with Disease Severity in Patients with Pulmonary Tuberculosis | ELIANA MUIS | 14 Nov 16:15-17:45 Uluwatu 3 OS 11 Oral Session 11: Tuberculosis Assembly |
| O-Q-012 | The Effect of Ethanol Extract Propolis (EEP) on the Level of IFN-γ and Superoxide Dismutase (SOD) Activities in Patients with MDR Tuberculosis | ARIANI PERMATASARI | 14 Nov 16:15-17:45 Uluwatu 3 OS 11 Oral Session 11: Tuberculosis Assembly |
| O-Q-013 | Tuberculosis in Indonesian hemodialysis patients: A single centre experience | RIRI ANDRI MUZASTI | 15 Nov 8:00-9:00 Uluwatu 3 OS 13 Oral Session 13: Tuberculosis Assembly |
| O-Q-014 | TREATMENT OUTCOMES AMONG PULMONARY AND EXTRA PULMONARY TUBERCULOSIS PATIENTS IN MALAYSIA | ABDUL RAZAK MUTTALIF | 15 Nov 8:00-9:00 Uluwatu 3 OS 13 Oral Session 13: Tuberculosis Assembly |
| O-Q-015 | Characteristics and problems of foreign tuberculosis treated in our hospital | JIN TAKASAKI | 15 Nov 8:00-9:00 Uluwatu 3 OS 13 Oral Session 13: Tuberculosis Assembly |
| O-Q-016 | TWO YEAR FOLLOW UP STUDY OF TB PATIENTS PUT ON DOTS FROM SOUTH INDIA | DR.K.VENUGOPAL | 15 Nov 8:00-9:00 Uluwatu 3 OS 13 Oral Session 13: Tuberculosis Assembly |
| O-Q-017 | The profile of interleukin (IL)-12p70 and IL-12p40 serum level among active tuberculosis patients, latent with positive interferon gamma release assay (IGRA), contact with negative IGRA | NUR AHMAD TABRI | 15 Nov 8:00-9:00 Uluwatu 3 OS 13 Oral Session 13: Tuberculosis Assembly |
| O-Q-018 | A study on inoculum density and reproducibility of drug susceptibility testing by DAC (Disc agarose channel) | HYEJIN KIM | 15 Nov 8:00-9:00 Uluwatu 3 OS 13 Oral Session 13: Tuberculosis Assembly |
| O-Q-019 | Comparative analysis of DU region in the Mycobacterium bovis BCG-Korea strain | EUN-HEE LEE | 15 Nov 9:00-10:00 Uluwatu 3 OS 14 Oral Session 14: Tuberculosis Assembly |
| O-Q-020 | Correlation between positivity of acid fast bacilli (AFB) and level of interferon-γ (IFN-γ) among tuberculosis patients in Makassar | ERWIN ARIEF | 15 Nov 9:00-10:00 Uluwatu 3 OS 14 Oral Session 14: Tuberculosis Assembly |
| O-Q-021 | A cross sectional study of Pengawas Minum Obat (PMO) in going hand in hand with tuberculosis patients in Jakarta Respiratory Center (JRC) – The Indonesian Association Against Tuberculosis | FABIANTO SANTOSO | 15 Nov 9:00-10:00 Uluwatu 3 OS 14 Oral Session 14: Tuberculosis Assembly |
| O-Q-022 | Clinical experience with immunotherapy regimens in TB patients | DMYTRO BUTOV | 15 Nov 9:00-10:00 Uluwatu 3 OS 14 Oral Session 14: Tuberculosis Assembly |
| O-Q-023 | Smoking and Alcohol Consumption as Risk Factors of Pulmonary Tuberculosis Development in Medan, Indonesia | BINTANG YINKE MAGDALENA SINAGA | 15 Nov 9:00-10:00 Uluwatu 3 OS 14 Oral Session 14: Tuberculosis Assembly |
| O-Q-024 | Magnetic bead protocol denoted cogent results for culturing Mycobacterium tuberculosis from sputum specimens. | SUNGWEON RYOO | 15 Nov 9:00-10:00 Uluwatu 3 OS 14 Oral Session 14: Tuberculosis Assembly |
home
